1-(3-dibenzofuran-3-ylbenzene-6-id-1-yl)-3-methyl-2H-benzimidazol-2-ide;1-[2,4-dimethyl-3-(4-phenylphenyl)benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;1-[3-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;1-methyl-3-(3-phenylbenzene-6-id-1-yl)-2H-benzimidazol-2-ide;1-methyl-3-[3-(4-phenylphenyl)benzene-6-id-1-yl]-2H-benzimidazol-2-ide;tetrakis(3-methyl-5-phenylpyrazol-1-ide);3-phenyl-1,4-diaza-2-azanidacyclopenta-3,5-diene;pentakis(platinum(4+))

C176H139N21OPt5 — CID 162286134

IUPAC1-(3-dibenzofuran-3-ylbenzene-6-id-1-yl)-3-methyl-2H-benzimidazol-2-ide;1-[2,4-dimethyl-3-(4-phenylphenyl)benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;1-[3-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;1-methyl-3-(3-phenylbenzene-6-id-1-yl)-2H-benzimidazol-2-ide;1-methyl-3-[3-(4-phenylphenyl)benzene-6-id-1-yl]-2H-benzimidazol-2-ide;tetrakis(3-methyl-5-phenylpyrazol-1-ide);3-phenyl-1,4-diaza-2-azanidacyclopenta-3,5-diene;pentakis(platinum(4+))
SMILESCN1[CH-]N(c2[c-]ccc(-c3ccc(-c4ccccc4)cc3)c2)c2ccccc21.CN1[CH-]N(c2[c-]ccc(-c3ccc4c(c3)oc3ccccc34)c2)c2ccccc21.CN1[CH-]N(c2[c-]ccc(-c3ccccc3)c2)c2ccccc21.Cc1c[c-]c(N2[CH-]N(C)c3ccccc32)c(C)c1-c1ccc(-c2ccccc2)cc1.Cc1cc(-c2[c-]cccc2)[n-]n1.Cc1cc(-c2[c-]cccc2)[n-]n1.Cc1cc(-c2[c-]cccc2)[n-]n1.Cc1cc(-c2[c-]cccc2)[n-]n1.Cc1cc(-c2ccccc2)cc(C)c1-c1cc[c-]c(N2[CH-]N(C)c3ccccc32)c1.[Pt+4].[Pt+4].[Pt+4].[Pt+4].[Pt+4].[c-]1ccccc1-c1ncn[n-]1
InChIInChI=1S/2C28H24N2.C26H18N2O.C26H20N2.C20H16N2.4C10H8N2.C8H5N3.5Pt/c1-20-16-24(22-10-5-4-6-11-22)17-21(2)28(20)23-12-9-13-25(18-23)30-19-29(3)26-14-7-8-15-27(26)30;1-20-13-18-25(30-19-29(3)26-11-7-8-12-27(26)30)21(2)28(20)24-16-14-23(15-17-24)22-9-5-4-6-10-22;1-27-17-28(24-11-4-3-10-23(24)27)20-8-6-7-18(15-20)19-13-14-22-21-9-2-5-12-25(21)29-26(22)16-19;1-27-19-28(26-13-6-5-12-25(26)27)24-11-7-10-23(18-24)22-16-14-21(15-17-22)20-8-3-2-4-9-20;1-21-15-22(20-13-6-5-12-19(20)21)18-11-7-10-17(14-18)16-8-3-2-4-9-16;4*1-8-7-10(12-11-8)9-5-3-2-4-6-9;1-2-4-7(5-3-1)8-9-6-10-11-8;;;;;/h4-12,14-19H,1-3H3;4-17,19H,1-3H3;2-7,9-17H,1H3;2-10,12-19H,1H3;2-10,12-15H,1H3;4*2-5,7H,1H3;1-4,6H;;;;;/q10*-2;5*+4
InChIKeyRAFKCHADZRASQJ-UHFFFAOYSA-N
MW3539.58 g/mol
LogP40.59
Rot. Bonds18

About 1-(3-dibenzofuran-3-ylbenzene-6-id-1-yl)-3-methyl-2H-benzimidazol-2-ide;1-[2,4-dimethyl-3-(4-phenylphenyl)benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;1-[3-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;1-methyl-3-(3-phenylbenzene-6-id-1-yl)-2H-benzimidazol-2-ide;1-methyl-3-[3-(4-phenylphenyl)benzene-6-id-1-yl]-2H-benzimidazol-2-ide;tetrakis(3-methyl-5-phenylpyrazol-1-ide);3-phenyl-1,4-diaza-2-azanidacyclopenta-3,5-diene;pentakis(platinum(4+))

1-(3-dibenzofuran-3-ylbenzene-6-id-1-yl)-3-methyl-2H-benzimidazol-2-ide;1-[2,4-dimethyl-3-(4-phenylphenyl)benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;1-[3-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;1-methyl-3-(3-phenylbenzene-6-id-1-yl)-2H-benzimidazol-2-ide;1-methyl-3-[3-(4-phenylphenyl)benzene-6-id-1-yl]-2H-benzimidazol-2-ide;tetrakis(3-methyl-5-phenylpyrazol-1-ide);3-phenyl-1,4-diaza-2-azanidacyclopenta-3,5-diene;pentakis(platinum(4+)) (PubChem CID 162286134) has the molecular formula C176H139N21OPt5 and a molecular weight of 3539.58 g/mol. Its IUPAC name is 1-(3-dibenzofuran-3-ylbenzene-6-id-1-yl)-3-methyl-2H-benzimidazol-2-ide;1-[2,4-dimethyl-3-(4-phenylphenyl)benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;1-[3-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;1-methyl-3-(3-phenylbenzene-6-id-1-yl)-2H-benzimidazol-2-ide;1-methyl-3-[3-(4-phenylphenyl)benzene-6-id-1-yl]-2H-benzimidazol-2-ide;tetrakis(3-methyl-5-phenylpyrazol-1-ide);3-phenyl-1,4-diaza-2-azanidacyclopenta-3,5-diene;pentakis(platinum(4+)).

Molecular Properties

Compound Name1-(3-dibenzofuran-3-ylbenzene-6-id-1-yl)-3-methyl-2H-benzimidazol-2-ide;1-[2,4-dimethyl-3-(4-phenylphenyl)benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;1-[3-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;1-methyl-3-(3-phenylbenzene-6-id-1-yl)-2H-benzimidazol-2-ide;1-methyl-3-[3-(4-phenylphenyl)benzene-6-id-1-yl]-2H-benzimidazol-2-ide;tetrakis(3-methyl-5-phenylpyrazol-1-ide);3-phenyl-1,4-diaza-2-azanidacyclopenta-3,5-diene;pentakis(platinum(4+))
PubChem CID162286134
Molecular FormulaC176H139N21OPt5
Molecular Weight3539.58 g/mol
Exact Mass3536.97
IUPAC Name1-(3-dibenzofuran-3-ylbenzene-6-id-1-yl)-3-methyl-2H-benzimidazol-2-ide;1-[2,4-dimethyl-3-(4-phenylphenyl)benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;1-[3-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;1-methyl-3-(3-phenylbenzene-6-id-1-yl)-2H-benzimidazol-2-ide;1-methyl-3-[3-(4-phenylphenyl)benzene-6-id-1-yl]-2H-benzimidazol-2-ide;tetrakis(3-methyl-5-phenylpyrazol-1-ide);3-phenyl-1,4-diaza-2-azanidacyclopenta-3,5-diene;pentakis(platinum(4+))
SMILESCN1[CH-]N(c2[c-]ccc(-c3ccc(-c4ccccc4)cc3)c2)c2ccccc21.CN1[CH-]N(c2[c-]ccc(-c3ccc4c(c3)oc3ccccc34)c2)c2ccccc21.CN1[CH-]N(c2[c-]ccc(-c3ccccc3)c2)c2ccccc21.Cc1c[c-]c(N2[CH-]N(C)c3ccccc32)c(C)c1-c1ccc(-c2ccccc2)cc1.Cc1cc(-c2[c-]cccc2)[n-]n1.Cc1cc(-c2[c-]cccc2)[n-]n1.Cc1cc(-c2[c-]cccc2)[n-]n1.Cc1cc(-c2[c-]cccc2)[n-]n1.Cc1cc(-c2ccccc2)cc(C)c1-c1cc[c-]c(N2[CH-]N(C)c3ccccc32)c1.[Pt+4].[Pt+4].[Pt+4].[Pt+4].[Pt+4].[c-]1ccccc1-c1ncn[n-]1
InChIInChI=1S/2C28H24N2.C26H18N2O.C26H20N2.C20H16N2.4C10H8N2.C8H5N3.5Pt/c1-20-16-24(22-10-5-4-6-11-22)17-21(2)28(20)23-12-9-13-25(18-23)30-19-29(3)26-14-7-8-15-27(26)30;1-20-13-18-25(30-19-29(3)26-11-7-8-12-27(26)30)21(2)28(20)24-16-14-23(15-17-24)22-9-5-4-6-10-22;1-27-17-28(24-11-4-3-10-23(24)27)20-8-6-7-18(15-20)19-13-14-22-21-9-2-5-12-25(21)29-26(22)16-19;1-27-19-28(26-13-6-5-12-25(26)27)24-11-7-10-23(18-24)22-16-14-21(15-17-22)20-8-3-2-4-9-20;1-21-15-22(20-13-6-5-12-19(20)21)18-11-7-10-17(14-18)16-8-3-2-4-9-16;4*1-8-7-10(12-11-8)9-5-3-2-4-6-9;1-2-4-7(5-3-1)8-9-6-10-11-8;;;;;/h4-12,14-19H,1-3H3;4-17,19H,1-3H3;2-7,9-17H,1H3;2-10,12-19H,1H3;2-10,12-15H,1H3;4*2-5,7H,1H3;1-4,6H;;;;;/q10*-2;5*+4
InChIKeyRAFKCHADZRASQJ-UHFFFAOYSA-N
XLogP40.59
TPSA193.38 Ų
H-Bond Donors
H-Bond Acceptors17
Rotatable Bonds18
Heavy Atoms203
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003539.58
LogP ≤ 540.59
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1017

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze 1-(3-dibenzofuran-3-ylbenzene-6-id-1-yl)-3-methyl-2H-benzimidazol-2-ide;1-[2,4-dimethyl-3-(4-phenylphenyl)benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;1-[3-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;1-methyl-3-(3-phenylbenzene-6-id-1-yl)-2H-benzimidazol-2-ide;1-methyl-3-[3-(4-phenylphenyl)benzene-6-id-1-yl]-2H-benzimidazol-2-ide;tetrakis(3-methyl-5-phenylpyrazol-1-ide);3-phenyl-1,4-diaza-2-azanidacyclopenta-3,5-diene;pentakis(platinum(4+)) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-(3-dibenzofuran-3-ylbenzene-6-id-1-yl)-3-methyl-2H-benzimidazol-2-ide;1-[2,4-dimethyl-3-(4-phenylphenyl)benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;1-[3-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;1-methyl-3-(3-phenylbenzene-6-id-1-yl)-2H-benzimidazol-2-ide;1-methyl-3-[3-(4-phenylphenyl)benzene-6-id-1-yl]-2H-benzimidazol-2-ide;tetrakis(3-methyl-5-phenylpyrazol-1-ide);3-phenyl-1,4-diaza-2-azanidacyclopenta-3,5-diene;pentakis(platinum(4+))?
The IUPAC name of 1-(3-dibenzofuran-3-ylbenzene-6-id-1-yl)-3-methyl-2H-benzimidazol-2-ide;1-[2,4-dimethyl-3-(4-phenylphenyl)benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;1-[3-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;1-methyl-3-(3-phenylbenzene-6-id-1-yl)-2H-benzimidazol-2-ide;1-methyl-3-[3-(4-phenylphenyl)benzene-6-id-1-yl]-2H-benzimidazol-2-ide;tetrakis(3-methyl-5-phenylpyrazol-1-ide);3-phenyl-1,4-diaza-2-azanidacyclopenta-3,5-diene;pentakis(platinum(4+)) (CID 162286134) is 1-(3-dibenzofuran-3-ylbenzene-6-id-1-yl)-3-methyl-2H-benzimidazol-2-ide;1-[2,4-dimethyl-3-(4-phenylphenyl)benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;1-[3-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;1-methyl-3-(3-phenylbenzene-6-id-1-yl)-2H-benzimidazol-2-ide;1-methyl-3-[3-(4-phenylphenyl)benzene-6-id-1-yl]-2H-benzimidazol-2-ide;tetrakis(3-methyl-5-phenylpyrazol-1-ide);3-phenyl-1,4-diaza-2-azanidacyclopenta-3,5-diene;pentakis(platinum(4+)).
What is the SMILES notation for 1-(3-dibenzofuran-3-ylbenzene-6-id-1-yl)-3-methyl-2H-benzimidazol-2-ide;1-[2,4-dimethyl-3-(4-phenylphenyl)benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;1-[3-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;1-methyl-3-(3-phenylbenzene-6-id-1-yl)-2H-benzimidazol-2-ide;1-methyl-3-[3-(4-phenylphenyl)benzene-6-id-1-yl]-2H-benzimidazol-2-ide;tetrakis(3-methyl-5-phenylpyrazol-1-ide);3-phenyl-1,4-diaza-2-azanidacyclopenta-3,5-diene;pentakis(platinum(4+))?
The canonical SMILES for 1-(3-dibenzofuran-3-ylbenzene-6-id-1-yl)-3-methyl-2H-benzimidazol-2-ide;1-[2,4-dimethyl-3-(4-phenylphenyl)benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;1-[3-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;1-methyl-3-(3-phenylbenzene-6-id-1-yl)-2H-benzimidazol-2-ide;1-methyl-3-[3-(4-phenylphenyl)benzene-6-id-1-yl]-2H-benzimidazol-2-ide;tetrakis(3-methyl-5-phenylpyrazol-1-ide);3-phenyl-1,4-diaza-2-azanidacyclopenta-3,5-diene;pentakis(platinum(4+)) is CN1[CH-]N(c2[c-]ccc(-c3ccc(-c4ccccc4)cc3)c2)c2ccccc21.CN1[CH-]N(c2[c-]ccc(-c3ccc4c(c3)oc3ccccc34)c2)c2ccccc21.CN1[CH-]N(c2[c-]ccc(-c3ccccc3)c2)c2ccccc21.Cc1c[c-]c(N2[CH-]N(C)c3ccccc32)c(C)c1-c1ccc(-c2ccccc2)cc1.Cc1cc(-c2[c-]cccc2)[n-]n1.Cc1cc(-c2[c-]cccc2)[n-]n1.Cc1cc(-c2[c-]cccc2)[n-]n1.Cc1cc(-c2[c-]cccc2)[n-]n1.Cc1cc(-c2ccccc2)cc(C)c1-c1cc[c-]c(N2[CH-]N(C)c3ccccc32)c1.[Pt+4].[Pt+4].[Pt+4].[Pt+4].[Pt+4].[c-]1ccccc1-c1ncn[n-]1.
What is the InChIKey of 1-(3-dibenzofuran-3-ylbenzene-6-id-1-yl)-3-methyl-2H-benzimidazol-2-ide;1-[2,4-dimethyl-3-(4-phenylphenyl)benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;1-[3-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;1-methyl-3-(3-phenylbenzene-6-id-1-yl)-2H-benzimidazol-2-ide;1-methyl-3-[3-(4-phenylphenyl)benzene-6-id-1-yl]-2H-benzimidazol-2-ide;tetrakis(3-methyl-5-phenylpyrazol-1-ide);3-phenyl-1,4-diaza-2-azanidacyclopenta-3,5-diene;pentakis(platinum(4+))?
The InChIKey is RAFKCHADZRASQJ-UHFFFAOYSA-N. The full InChI is InChI=1S/2C28H24N2.C26H18N2O.C26H20N2.C20H16N2.4C10H8N2.C8H5N3.5Pt/c1-20-16-24(22-10-5-4-6-11-22)17-21(2)28(20)23-12-9-13-25(18-23)30-19-29(3)26-14-7-8-15-27(26)30;1-20-13-18-25(30-19-29(3)26-11-7-8-12-27(26)30)21(2)28(20)24-16-14-23(15-17-24)22-9-5-4-6-10-22;1-27-17-28(24-11-4-3-10-23(24)27)20-8-6-7-18(15-20)19-13-14-22-21-9-2-5-12-25(21)29-26(22)16-19;1-27-19-28(26-13-6-5-12-25(26)27)24-11-7-10-23(18-24)22-16-14-21(15-17-22)20-8-3-2-4-9-20;1-21-15-22(20-13-6-5-12-19(20)21)18-11-7-10-17(14-18)16-8-3-2-4-9-16;4*1-8-7-10(12-11-8)9-5-3-2-4-6-9;1-2-4-7(5-3-1)8-9-6-10-11-8;;;;;/h4-12,14-19H,1-3H3;4-17,19H,1-3H3;2-7,9-17H,1H3;2-10,12-19H,1H3;2-10,12-15H,1H3;4*2-5,7H,1H3;1-4,6H;;;;;/q10*-2;5*+4.
What are the key properties of 1-(3-dibenzofuran-3-ylbenzene-6-id-1-yl)-3-methyl-2H-benzimidazol-2-ide;1-[2,4-dimethyl-3-(4-phenylphenyl)benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;1-[3-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;1-methyl-3-(3-phenylbenzene-6-id-1-yl)-2H-benzimidazol-2-ide;1-methyl-3-[3-(4-phenylphenyl)benzene-6-id-1-yl]-2H-benzimidazol-2-ide;tetrakis(3-methyl-5-phenylpyrazol-1-ide);3-phenyl-1,4-diaza-2-azanidacyclopenta-3,5-diene;pentakis(platinum(4+))?
1-(3-dibenzofuran-3-ylbenzene-6-id-1-yl)-3-methyl-2H-benzimidazol-2-ide;1-[2,4-dimethyl-3-(4-phenylphenyl)benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;1-[3-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;1-methyl-3-(3-phenylbenzene-6-id-1-yl)-2H-benzimidazol-2-ide;1-methyl-3-[3-(4-phenylphenyl)benzene-6-id-1-yl]-2H-benzimidazol-2-ide;tetrakis(3-methyl-5-phenylpyrazol-1-ide);3-phenyl-1,4-diaza-2-azanidacyclopenta-3,5-diene;pentakis(platinum(4+)) has a molecular weight of 3539.58 g/mol, XLogP of 40.59, 18 rotatable bonds, 0 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(3-dibenzofuran-3-ylbenzene-6-id-1-yl)-3-methyl-2H-benzimidazol-2-ide;1-[2,4-dimethyl-3-(4-phenylphenyl)benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;1-[3-(2,6-dimethyl-4-phenylphenyl)benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;1-methyl-3-(3-phenylbenzene-6-id-1-yl)-2H-benzimidazol-2-ide;1-methyl-3-[3-(4-phenylphenyl)benzene-6-id-1-yl]-2H-benzimidazol-2-ide;tetrakis(3-methyl-5-phenylpyrazol-1-ide);3-phenyl-1,4-diaza-2-azanidacyclopenta-3,5-diene;pentakis(platinum(4+)) is sourced from PubChem (CID 162286134), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).